Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Passive antibody therapies: progress and continuing challenges.

A Casadevall1

  • 1Division of Infectious Diseases of the Department of Medicine, Department of Microbiology and Immunology of the Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, New York, 10461, USA.

Clinical Immunology (Orlando, Fla.)
|September 25, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapy.

Scientific reports·2018
Same author

Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein.

British journal of cancer·2013
Same author

Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma.

Journal of skin cancer·2013
Same author

Increased chitinase expression and fungal-specific antibodies in the bronchoalveolar lavage fluid of asthmatic children.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2011
Same author

Toward developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigens.

Mycopathologia·2011
Same author

Pre-clinical evaluation and efficacy studies of a melanin-binding IgM antibody labeled with 188Re against experimental human metastatic melanoma in nude mice.

Cancer biology & therapy·2008
Same journal

Selective immune modulation in seminal plasma during simian immunodeficiency virus infection despite systemic inflammation.

Clinical immunology (Orlando, Fla.)·2026
Same journal

EIF4A3/ALKBH5 axis promotes meningioma cell growth, invasion, and resistance to CD8<sup>+</sup> T cell-mediated cytotoxicity by inducing M2 polarization.

Clinical immunology (Orlando, Fla.)·2026
Same journal

A novel JAK1 mutation identified in a patient with severe atopic dermatitis phenotype: Mechanistic insights and IL-4Rα targeted therapy.

Clinical immunology (Orlando, Fla.)·2026
Same journal

VNN1 aggravates sepsis by promoting inflammation and oxidative stress through PPARγ signaling VNN1 in sepsis.

Clinical immunology (Orlando, Fla.)·2026
Same journal

Comparison between glioblastoma and brain metastases: How epigenetic remodeling can enhance immunotherapy.

Clinical immunology (Orlando, Fla.)·2026
Same journal

JAK-STAT3-MYC axis defines pathogenic stem cell-like memory CD4<sup>+</sup> T cells in rheumatoid arthritis.

Clinical immunology (Orlando, Fla.)·2026
See all related articles

Antibody-based therapies are emerging as crucial treatments for various diseases. Advances in production technology are driving their development, offering unique advantages over traditional chemotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Antibody-based therapies are increasingly used for viral infections, inflammatory disorders, and malignancies.
  • Advances in antibody production technology and the need for novel therapeutics fuel this resurgence.
  • Numerous antibody preparations are in clinical use or advanced development.

Purpose of the Study:

  • To review the current landscape of antibody-based therapies.
  • To discuss the advantages and disadvantages of antibody therapies compared to chemotherapy.
  • To highlight the future directions for antibody-based therapeutic development.

Main Methods:

  • Review of recent literature on antibody-based therapies.
  • Analysis of clinical use, development status, and therapeutic applications.

Related Experiment Videos

  • Comparison of antibody therapies with conventional chemotherapy.

    • Main Results:

    • Antibody therapies offer advantages such as specificity and unique biological functions.
    • Disadvantages include high costs and limited market size, impacting commercialization.
    • These therapies show promise in treating conditions with unmet medical needs.

    Conclusions:

    • Antibody-based therapies are effective in clinical situations lacking other treatments.
    • Further clinical and immunological research is essential for optimal use and understanding of antibody mechanisms.
    • Continued development requires addressing cost and market challenges.